P043-0864 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide

P043-0864 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide
P043-0864 Screening compound: N-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound P043-0864
N-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P043-0864

Molecular Formula

C21H18FN3O5 (C21 H18 FN3 O5)

Compound Name

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-1,4-dihydropyridazine-3-carboxamide

IUPAC name

N-(23-dihydro-14-benzodioxin-6-yl)-6-ethoxy-1-(4-fluorophenyl)-4-oxo-14-dihydropyridazine-3-carboxamide

SMILES

CCOC(N(c(cc1)ccc1F)N=C1C(Nc(cc2)cc3c2OCCO3)=O)=CC1=O

InChI

InChI=1S/C21H18FN3O5/c1-2-28-19-12-16(26)20(24-25(19)15-6-3-13(22)4-7-15)21(27)23-14-5-8-17-18(11-14)30-10-9-29-17/h3-8,11-12H,2,9-10H2,1H3,(H,23,27)

InChI Key

RQRIHXGDDSFKLH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27560292

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.39

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.596

Distribution Coefficient, logD

2.548

Water Solubility, LogSw

-3.11

Polar Surface Area

73.938

Acid Dissociation Constant (pKa)

8.33

Base Dissociation Constant (pKb)

-0.91

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

19.00

P043-0864 in Drug Discovery

Included in Screening Libraries

Anti-Inflammatory Library (24602 compounds)

Anticancer Library (62698 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Immune system
  • Cancer
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with P043-0864 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P043-0864?
Check Price and Availability of P043-0864, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P043-0864 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P043-0864
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P043-0864
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P043-0864 available by request